Paragraph 4

Changes not yet applied. Later legislation changes this provision in ways not yet written into the text below:

Sch. 5 para. 1A(1A) inserted by Medicines for Human Use and Medical Devices (Fees Amendments) 2004 reg. 14
Sch 5, para 1A added by Medicines for Human Use (Fees and Miscellaneous Amendments) 2003 reg 13(1), (2)
Sch 5, para 2 am by Medicines for Human Use (Fees and Miscellaneous Amendments) 2003 reg 13(1), (3)
Sch 5, para 2C added by Medicines for Human Use (Fees Amendments) 2005 reg 5
Sch.5, para.3(1)(c) amended by Medicines (Products for Human Use—Fees) 1996 reg.7(1)
Sch.5, para.4A added by Medicines (Products for Human Use—Fees) 1996 reg.7(2)
Sch.5, para,6(3) revoked by Medicines (Products for Human Use—Fees) 1996 reg.7(3)
Sch.5, para.7 added by Medicines (Products for Human Use—Fees) 1996 reg.7(4)
Sch 5, para 2A added by Medicines for Human Use and Medical Devices (Fees and Miscellaneous Amendments) 2001 reg 5(12)
Sch 5, para 6 am by Medicines for Human Use and Medical Devices (Fees and Miscellaneous Amendments) 2001 reg 5(13)
Sch 5, para 2 am by Medicines for Human Use and Medical Devices(Fees Amendments) 2003 reg 4(1), (8)(a)
Sch 5, para 5A added by Medicines for Human Use and Medical Devices(Fees Amendments) 2003 reg 4(1), (8)(b)
Sch. 5 para. 3(1) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(a)(i)
Sch. 5 para. 3(1) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(a)(ii)
Sch. 5 para. 3(1) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(a)(iii)
Sch. 5 para. 3(1)(a) words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(a)(iv)
Sch. 5 para. 3(3) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(b)(i)
Sch. 5 para. 3(3) words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(b)(ii)
Sch. 5 para. 3(3) words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(2)(b)(iii)
Sch. 5 para. 4 words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(3)
Sch. 5 para. 4A words substituted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(4)
Sch. 5 para. 5(1) Sch. 5 para. 5(5) renumbered as Sch 5. para. 5(1) by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(5)
Sch. 5 para. 5(1) words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(5)(a)(i)
Sch. 5 para. 5(1) words inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(5)(a)(ii)
Sch. 5 para. 5(2) inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(5)(b)
Sch. 5 para. 8 inserted by Medicines for Human Use (Clinical Trials Fees Amendments) 2004 reg. 13(6)
Sch 5, para 2B rev in pt by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (2)
Sch 5, para 2D added by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (3)
Sch 5, para 3 am by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (4)(a), (b)(i)
Sch 5, para 3 rev in pt by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (4)(b)(ii)
Sch 5, para 4A am by Medicines for Human Use (Fees Amendments) 2005 reg 19(1), (5)
Sch. 5 para. 6 words substituted by Medicines (Codification Amendments Etc.) 2002 reg. 16(l)
Sch 5, para 2B added by Medicines for Human Use and Medical Devices (Fees and Miscellaneous Amendments) 2002 reg 5(1), (8)

Where an application for the grant of, or for a variation to, a manufacturer’s or a wholesale dealer’s licence is withdrawn before determination by the licensing authority, the following percentage of the fee otherwise payable under regulation 4(a) or 7(1) in connection with that application shall be refunded or, if it has not yet been paid, shall be waived—

(a)

if the application is withdrawn before any inspection in connection with that application has been made, 90%;

(b)

if such an inspection has been made, 50%.